Update on Adrenarche—Still a Mystery
The Journal of Clinical Endocrinology & Metabolism · 2024
DOI: 10.1210/clinem/dgae008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Philipp Augsburger und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Endocrinology, Diabetology, and Metabolism, Inselspital, Bern University Hospital, 3010 Bern, Switzerland. Hauptthemen laut MEDLINE: Adrenarche. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 321 Literaturangaben. Gefördert von: Sigrid Jusélius Foundation, Foundation for Pediatric Research, Swiss National Science Foundation.
Abstract (Originalsprache)
Context
Adrenarche marks the timepoint of human adrenal development when the cortex starts secreting androgens in increasing amounts, in healthy children at age 8–9 years, with premature adrenarche (PA) earlier. Because the molecular regulation and significance of adrenarche are unknown, this prepubertal event is characterized descriptively, and PA is a diagnosis by exclusion with unclear long-term consequences. Evidence Acquisition We searched the literature of the past 5 years, including original articles, reviews, and meta-analyses from PubMed, ScienceDirect, Web of Science, Embase, and Scopus, using search terms adrenarche, pubarche, DHEAS, steroidogenesis, adrenal, and zona reticularis. Evidence Synthesis Numerous studies addressed different topics of adrenarche and PA. Although basic studies on human adrenal development, zonation, and zona reticularis function enhanced our knowledge, the exact mechanism leading to adrenarche remains unsolved. Many regulators seem involved. A promising marker of adrenarche (11-ketotestosterone) was found in the 11-oxy androgen pathway. By current definition, the prevalence of PA can be as high as 9% to 23% in girls and 2% to 10% in boys, but only a subset of these children might face related adverse health outcomes.
Conclusion
New criteria for defining adrenarche and PA are needed to identify children at risk for later disease and to spare children with a normal variation. Further research is therefore required to understand adrenarche. Prospective, long-term studies should characterize prenatal or early postnatal developmental pathways that modulate trajectories of birth size, early postnatal growth, childhood overweight/obesity, adrenarche and puberty onset, and lead to abnormal sexual maturation, fertility, and other adverse outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Endocrinology, Diabetology, and Metabolism, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.
- Department of BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland.
- Kuopio Pediatric Research Unit (KuPRU), University of Eastern Finland and Kuopio University Hospital, 70029 Kuopio, Finland.
ORCID-Profile: Jani Liimatta, Christa E Flück
Förderung
- Sigrid Jusélius Foundation
- Foundation for Pediatric Research
- Swiss National Science Foundation
Zitieren
APA
Augsburger, P., Liimatta, J., & Flück, C. E. (2024). Update on Adrenarche—Still a Mystery. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae008
Vancouver
Augsburger P, Liimatta J, Flück CE. Update on Adrenarche—Still a Mystery. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae008
BibTeX
@article{Augsburger2024,
author = {Augsburger, Philipp and Liimatta, Jani and Flück, Christa E},
title = {Update on Adrenarche—Still a Mystery},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2024},
doi = {10.1210/clinem/dgae008}
}
EUVIMED